AbbVie
ABBV
#25
Rank
$369.25 B
Marketcap
$209.17
Share price
-0.40%
Change (1 day)
17.16%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : $131.79 Billion USD

According to AbbVie's latest financial reports the company's total liabilities are $131.79 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31$131.79 B6.02%
2023-12-31$124.31 B2.3%
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.54%
2014-12-31$25.77 B4.31%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B211.57%
2011-12-31$7.58 B39.72%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$124.89 B-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$76.21 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$64.44 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$85.96 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.74 B-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.33 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.19 B-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
$63.16 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.12 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA